A detailed history of Walter & Keenan Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Walter & Keenan Wealth Management LLC holds 9,860 shares of AMGN stock, worth $2.59 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
9,860
Previous 9,857 0.03%
Holding current value
$2.59 Million
Previous $3.08 Million 3.15%
% of portfolio
0.97%
Previous 0.98%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$309.38 - $337.38 $928 - $1,012
3 Added 0.03%
9,860 $3.18 Million
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $8,408 - $10,217
-32 Reduced 0.32%
9,857 $3.08 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $15,594 - $18,824
58 Added 0.59%
9,889 $2.81 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $255 - $288
1 Added 0.01%
9,831 $2.83 Million
Q2 2023

Jul 28, 2023

BUY
$214.27 - $253.37 $20,141 - $23,816
94 Added 0.97%
9,830 $2.18 Million
Q1 2023

Apr 26, 2023

SELL
$225.79 - $275.2 $158,053 - $192,640
-700 Reduced 6.71%
9,736 $2.35 Million
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $89,321 - $113,493
390 Added 3.88%
10,436 $2.74 Million
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $31,873 - $35,947
142 Added 1.43%
10,046 $2.26 Million
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $23,071 - $25,674
-100 Reduced 1.0%
9,904 $2.41 Million
Q4 2021

Jan 24, 2022

BUY
$198.88 - $227.6 $69,806 - $79,887
351 Added 3.64%
10,004 $2.25 Million
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $39,057 - $45,760
184 Added 1.94%
9,653 $2.05 Million
Q2 2021

Jul 13, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 1.05%
9,469 $2.31 Million
Q1 2021

Apr 30, 2021

SELL
$221.91 - $258.6 $396,553 - $462,118
-1,787 Reduced 15.74%
9,569 $2.38 Million
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $14,064 - $16,748
65 Added 0.58%
11,356 $2.61 Million
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $11,732 - $13,047
-50 Reduced 0.44%
11,291 $2.87 Million
Q2 2020

Jul 16, 2020

SELL
$197.81 - $242.74 $3.51 Million - $4.31 Million
-17,752 Reduced 61.02%
11,341 $2.68 Million
Q1 2020

Apr 14, 2020

BUY
$182.24 - $241.7 $3.4 Million - $4.51 Million
18,652 Added 178.64%
29,093 $5.76 Million
Q4 2019

Jan 29, 2020

SELL
$189.21 - $243.2 $732,810 - $941,913
-3,873 Reduced 27.06%
10,441 $2.52 Million
Q3 2019

Oct 28, 2019

BUY
$174.11 - $208.62 $655,350 - $785,245
3,764 Added 35.68%
14,314 $2.77 Million
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $58,344 - $68,393
350 Added 3.43%
10,550 $1.94 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $82,295 - $92,765
455 Added 4.67%
10,200 $1.94 Million
Q4 2018

Feb 01, 2019

BUY
$178.4 - $208.25 $205,160 - $239,487
1,150 Added 13.38%
9,745 $18.2 Million
Q3 2018

Oct 29, 2018

SELL
$185.29 - $208.89 $92,645 - $104,445
-500 Reduced 5.5%
8,595 $1.78 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $25,737 - $28,909
155 Added 1.73%
9,095 $1.68 Million
Q1 2018

May 04, 2018

BUY
$169.43 - $198.0 $58,453 - $68,310
345 Added 4.01%
8,940 $1.52 Million
Q4 2017

Jan 23, 2018

BUY
$168.79 - $188.59 $18,566 - $20,744
110 Added 1.3%
8,595 $1.5 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $1.42 Million - $1.62 Million
8,485
8,485 $1.58 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Walter & Keenan Wealth Management LLC Portfolio

Follow Walter & Keenan Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walter & Keenan Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Walter & Keenan Wealth Management LLC with notifications on news.